(19)
(11)
EP 0 689 450 A1
(12)
(43)
Date of publication:
03.01.1996
Bulletin 1996/01
(21)
Application number:
94911588.0
(22)
Date of filing:
14.03.1994
(51)
International Patent Classification (IPC):
G01N
33/
566
( . )
A61K
35/
30
( . )
A61K
35/
56
( . )
A61K
45/
00
( . )
A61P
9/
00
( . )
A61P
43/
00
( . )
G01N
33/
68
( . )
A01N
63/
02
( . )
A61K
35/
34
( . )
A61K
38/
00
( . )
A61K
49/
00
( . )
A61P
9/
06
( . )
C07K
14/
435
( . )
(86)
International application number:
PCT/US1994/002750
(87)
International publication number:
WO 1994/021278
(
29.09.1994
Gazette 1994/22)
(84)
Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
(30)
Priority:
18.03.1993
US 19930033388
(71)
Applicant:
NPS PHARMACEUTICALS, INC.
Salt Lake City Utah 84108 (US)
(72)
Inventors:
SANGUINETTI, Michael C.
Park City, UT 84060 (US)
MUELLER, Alan L.
Salt Lake City, UT 84105 (US)
(74)
Representative:
Patentanwälte Viering, Jentschura & Partner
Postfach 22 14 43
D-80504 München
D-80504 München (DE)
(54)
POTASSIUM CHANNEL BLOCKING COMPOUNDS AND THEIR USE